A decade or so ago, a spate of high profile legal cases arose in which people were accused, and often convicted, on the basis of ?recovered memories.? These memories, usually recollections of childhood abuse, arose years after the incident occurred and often during intensive psychotherapy.
Two new studies in the June issue of the Journal of Periodontology suggest that periodontal diseases are a threat to women of all ages due to hormonal fluctuations that occur at various stages of their lives.
A recently issued update to the 2004 American College of Chest Physicians (ACCP) Pulmonary Arterial Hypertension Guidelines recommends the use of sildenafil in treating patients with pulmonary arterial hypertension (PAH), reporting a substantial benefit.
GlaxoSmithKline plc announced results from an international, pivotal Phase III study of its investigational non-peptide oral platelet growth factor, Revolade? (eltrombopag). Data from this study showed that eltrombopag at 50-75mg once daily resulted in a statistically significant increase in platelet counts and also reduced bleeding in adult patients with chronic idiopathic thrombocytopenia purpura (ITP).
Centocor, Inc. and Schering-Plough Corporation (NYSE: SGP) announced that the European Commission has approved a new indication for REMICADE(R) (infliximab) allowing for the treatment of severe, active Crohn’s disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an immunomodulator and primary nutrition therapy, or who are intolerant to, or have contraindications for, such therapies.
The findings in a new study on Viagra might seem obvious — the sexual satisfaction of couples involving a male with erectile dysfunction improved significantly when the man took Viagra. The novelty is that researchers cared what the woman thought.
Northwestern University researchers have discovered a drug that slows ? and may even halt ? the progression of Parkinson?s disease. The drug rejuvenates aging dopamine cells, whose death in the brain causes the symptoms of this devastating and widespread disease.
Health Protection Agency HPA, UK confirms that a review of patients’ case notes in hospitals across England and Scotland has been carried out.
Breast cancer survivors who eat a healthy diet and exercise moderately can reduce their risk of dying from breast cancer by half, regardless of their weight, suggests a new longitudinal study from the Moores Cancer Center at the University of California, San Diego (UCSD).
By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.